Evidence map›Paper›PMID 40677772›Full record

ArticleCanadian liver journal2024

Risk Evaluation and Recipient Selection in Adult Liver Transplantation: A Mixed-Methods Survey.

Christian Vincelette, Philémon Mulongo, Jeanne-Marie Giard, Éva Amzallag, Adrienne Carr, Prosanto Chaudhury, Khaled Dajani, Réné Fugère, Nelson Gonzalez-Valencia, Alexandre Joosten and 9 more

Abstract read
In one paragraph

Article in Canadian liver journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Commentary on Vincelette et al.Canadian liver journal · 2025
    Article
  2. Response to Commentary on Vincelette et al.Canadian liver journal · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Christian VinceletteHealth Innovation and Evaluation Hub, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.
Philémon MulongoSchool of Public Health, Université de Montréal, Montréal, Quebec, Canada.
Jeanne-Marie GiardDepartment of Medicine, Liver Disease Division, Centre hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
Éva AmzallagHealth Innovation and Evaluation Hub, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.
Adrienne CarrDepartment of Anesthesiology, Pain Management & Perioperative Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Prosanto ChaudhuryDepartment of Surgery, McGill University Health Centre, Montréal, Quebec, Canada.
Khaled DajaniDepartment of Surgery, University Health Centre, University of Alberta, Edmonton, Alberta, Canada.
Réné FugèreCanadian Donation and Transplantation Research Program, Edmonton, Alberta, Canada.
Nelson Gonzalez-ValenciaDepartment of Anesthesiology and Perioperative Medicine, Western University and London Health Sciences Centre, London, Ontario, Canada.
Alexandre JoostenDepartment of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, United States.
Stanislas KandelmanDepartment of Anesthesiology, McGill University Health Centre, Montréal, Quebec, Canada.
Constantine KarvellasDivision of Gastroenterology (Liver Unit), Department of Critical Care Medicine, University of Alberta, Edmonton, Alberta, Canada.
Stuart A McCluskeyDepartment of Anesthesia and Pain Management, Toronto General Hospital, Toronto, Ontario, Canada.
Timur ÖzelselDepartment of Anesthesiology & Pain Medicine, University of Alberta, Edmonton, Alberta, Canada.
Jeieung ParkDepartment of Anesthesiology and Perioperative Care, Vancouver General Hospital, Vancouver, British Columbia, Canada.
Ève SimoneauHepatobiliary Division, Department of Surgery, Centre hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
Helen TrottierDepartment of Social and Preventive Medicine, École de santé publique de l'Université de Montréal, Montréal, Quebec, Canada.
Michaël ChasséDepartment of Anesthesiology, Pain Management & Perioperative Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
François Martin CarrierDepartment of Anesthesiology, Pain Management & Perioperative Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Liver transplant (LT) is the definitive treatment for end-stage liver disease. Limited resources and important post-operative implications for recipients compel judicious risk stratification and patient selection. However, little is known about the factors influencing physicians' assessment regarding patient selection for LT and risk evaluation. Methods: We conducted a mixed-methods, cross-sectional survey involving Canadian hepatologists, anesthesiologists, LT surgeons, and French anesthesiologists. The survey contained quantitative questions and a vignette-based qualitative substudy about risk assessment and patient selection for LT. Descriptive statistics and qualitative content analyses were used. Results: We obtained answers from 129 physicians, and 63 participated in the qualitative substudy. We observed considerable variability in risk assessment prior to LT and identified many factors perceived to increase the risk of complications. Clinicians reported that the acceptable incidence of at least 1 severe post-operative complication for a LT program was 20% (95% CI: 20-30%). They identified the presence of any comorbidity as increasing the risk of different post-operative complications, especially acute kidney injury and cardiovascular complications. Frailty and functional disorders, severity of the liver disease, renal failure and cardiovascular comorbidities prior to LT emerged as important risk factors for post-operative morbidity. Most respondents were willing to pursue LT in patients with grade III acute-on-chronic liver failure but were less often willing to do so when faced with the uncertainty of a clinical example. Conclusions: Clinicians had a heterogeneous appraisal of the post-operative risk of complications following LT, as well as factors considered in risk assessment.

Indexed as

liver transplantationmixed methodspatient selectionrisk evaluationsurvey

Identifiers

PMID40677772
PMCPMC12269329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.